New Grant from the Hurka-Foundation

Gerhard Schratt received a grant over 93'900 CHF from the Dr. Wilhelm Hurka Stiftung for projects on Parkinson’s Disease and related Neurodegenerative Disorders. This project will explore the potential of antisense oligonucleotides targeting microRNAs to prevent synapse loss, mitochondrial dysfunction and cell death in a human neuron culture model of Parkinson’s Disease. This represents a first step towards the development of antisense oligonucleotide therapies for Parkinson’s Disease.